Nurse PrescriberPub Date : 2004-07-01DOI: 10.1017/S146711580400135X
John Adams
{"title":"Prescribing: the ethical dimension","authors":"John Adams","doi":"10.1017/S146711580400135X","DOIUrl":"https://doi.org/10.1017/S146711580400135X","url":null,"abstract":"Summary Prescribers face a range of ethical dilemmas in their everyday practice. In this article, the principles-based approach to biomedical ethics developed by Beauchamp and Childress is outlined, with a particular focus on ‘respect for autonomy’. It is argued that the purpose of ethical reflection is to deepen and enrich more general reflection about clinical practice, rather than to provide definitive answers to dilemmas in prescribing.","PeriodicalId":117012,"journal":{"name":"Nurse Prescriber","volume":"89 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132170340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nurse PrescriberPub Date : 2004-04-01DOI: 10.1017/S1467115804000689
S. Hemingway, M. Mcallister, K. Bailey, K. Coates, S. Mitchell, M. Fenwick
{"title":"Nurse Prescribing in Mental Health Care: What can the USA teach us?","authors":"S. Hemingway, M. Mcallister, K. Bailey, K. Coates, S. Mitchell, M. Fenwick","doi":"10.1017/S1467115804000689","DOIUrl":"https://doi.org/10.1017/S1467115804000689","url":null,"abstract":"","PeriodicalId":117012,"journal":{"name":"Nurse Prescriber","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123114054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nurse PrescriberPub Date : 2004-03-01DOI: 10.1017/S1467115804000318
C. Emery
{"title":"Oropharyngeal Candidiasis: A review of Current Intervention Strategies","authors":"C. Emery","doi":"10.1017/S1467115804000318","DOIUrl":"https://doi.org/10.1017/S1467115804000318","url":null,"abstract":"Summary This article sets out to review recent research studies pertaining to the drug treatment of oropharyngeal candidiasis in infants. The main aims of treatment programmes are to resolve signs and symptoms of the infection; and minimise drug induced resistance, with minimal adverse side effects. A search for clinical evidence using Medline, Nursing Index and Embase between 1995 and 2003, produces no systemic reviews, no placebo controlled trials only three random control trials for the treatment of oropharyngeal candidiasis in infants. Three independent randomised control trials with samples of infants with oropharyngeal candidiasis (who were not immuno-compromised), compare the three main drug treatments of choice for infants, i.e. miconazole gel, clotrimazole (nystatin) suspension, and fluconazole suspension. The randomised trial of these infants found that miconazole gel had a significantly higher cure rate compared with nystatin suspension. At day 12 of the trial there was a 99% cure rate with the use of miconazole gel (25 mg QDS) compared to only a cure rate of 54% with nystatin suspension (100 000 IU QDS) (P>","PeriodicalId":117012,"journal":{"name":"Nurse Prescriber","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116154405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nurse PrescriberPub Date : 2004-02-01DOI: 10.1017/S1467115804000173
L. Metcalfe
{"title":"Monitoring skills: diabetes","authors":"L. Metcalfe","doi":"10.1017/S1467115804000173","DOIUrl":"https://doi.org/10.1017/S1467115804000173","url":null,"abstract":"Summary The extended independent and supplementary nurse prescribing programme implemented in 2003 is anticipated to have the potential to improve patient care by enabling faster access to medicine for people with chronic conditions such as Diabetes. Diabetes mellitus is a progressive, life–long, chronic condition which affects an estimated 1.4 million people in the UK and inevitably requires medication to control symptoms and prevent complications associated with the disease. The supplementary prescribing option of nurse prescribing is an opportunity for Diabetes Specialist Nurses (DSN) to provide timely and appropriate clinical management for patients with diabetes within an agreed management plan. The clinical management plan (CMP) is a patient specific document and can only be implemented to enable supplementary nurse prescribing upon agreement by the individual patient, the independent prescriber (doctor or dentist and supplementary prescriber (nurse or pharmacist). The CMP allows the DSN to manage the treatment of the patient by modifying diabetes therapies tailored to the needs of the individual to achieve treatment goals. The use of a patient specific CMP compliments the National service Framework for diabetes requirement that all patients have a care plan. Involving the patient by seeking agreement to implement the CMP may improve concordance and compliance with therapies and treatment decisions. Monitoring diabetes control is essential from diagnosis as the information received provides valuable feedback as to the effectiveness of therapies. Comprehensive diabetes education should be tailored to empower the patient with knowledge and skills to manage this chronic condition regardless of treatment regimes. Consideration should always be given to the type of diabetes, the potential effects on lifestyle and treatment options available today.","PeriodicalId":117012,"journal":{"name":"Nurse Prescriber","volume":"64 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127276900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}